Daljit Singh Aurora
Title: Chief Operating and Development Officer · Neumora Therapeutics, Inc.
- 2025
- Aug 21, 2026
- 5
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Daljit Singh Aurora files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- ARCH Venture Partners X, LLC - $5.00M in NMRA purchases and sales in the last 12 months
- ARCH Venture Partners XII, LLC - $5.00M in NMRA purchases and sales in the last 12 months
- Kristina Burow - $5.00M in NMRA purchases and sales in the last 12 months
- Paul L. Berns - $34K in NMRA purchases and sales in the last 12 months
- Joshua Pinto - $21K in NMRA purchases and sales in the last 12 months
- Michael Lee Milligan - $5K in NMRA purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Daljit Singh Aurora?
Daljit Singh Aurora is a corporate insider, tracked as Title: Chief Operating and Development Officer of Neumora Therapeutics, Inc. (NMRA). InsiderAlpha holds 5 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Daljit Singh Aurora submitted recently?
2 primary Form 4 filings in the last 90 days, covering 1 company.
Has Daljit Singh Aurora been buying or selling stock?
Recorded transactions: 0 open-market purchases and 13 open-market sales ($1.03M) across all tracked filings.
